These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

84 related items for PubMed ID: 23318323

  • 1. Escitalopram for the prevention of peginterferon-α2a-associated depression.
    Landman GW.
    Ann Intern Med; 2013 Jan 15; 158(2):139-40. PubMed ID: 23318323
    [No Abstract] [Full Text] [Related]

  • 2. Escitalopram for the prevention of peginterferon-α2a-associated depression.
    Schaefer M, Berg T, Sarkar S, Neumann K.
    Ann Intern Med; 2013 Jan 15; 158(2):140. PubMed ID: 23318324
    [No Abstract] [Full Text] [Related]

  • 3. Escitalopram for the prevention of peginterferon-α2a-associated depression in hepatitis C virus-infected patients without previous psychiatric disease: a randomized trial.
    Schaefer M, Sarkar R, Knop V, Effenberger S, Friebe A, Heinze L, Spengler U, Schlaepfer T, Reimer J, Buggisch P, Ockenga J, Link R, Rentrop M, Weidenbach H, Fromm G, Lieb K, Baumert TF, Heinz A, Discher T, Neumann K, Zeuzem S, Berg T.
    Ann Intern Med; 2012 Jul 17; 157(2):94-103. PubMed ID: 22801672
    [Abstract] [Full Text] [Related]

  • 4. Summaries for Patients. Prevention of depression in patients treated for chronic hepatitis C virus infection with interferon-alpha.
    Ann Intern Med; 2012 Jul 17; 157(2):I-40. PubMed ID: 22801693
    [No Abstract] [Full Text] [Related]

  • 5. [Escitalopram for intervention of psychiatric adverse events during peginterferon-alfa-2a and ribavirin treatment for chronic hepatitis C].
    Qi M, Zhou B, Su M, Pan J, Zhang H.
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Jul 17; 33(7):1012-6. PubMed ID: 23895843
    [Abstract] [Full Text] [Related]

  • 6. Therapy of interferon-induced depression in chronic hepatitis C with citalopram: a randomised, double-blind, placebo-controlled study.
    Kraus MR, Schäfer A, Schöttker K, Keicher C, Weissbrich B, Hofbauer I, Scheurlen M.
    Gut; 2008 Apr 17; 57(4):531-6. PubMed ID: 18079286
    [Abstract] [Full Text] [Related]

  • 7. Escitalopram ameliorates prolonged depression with psychotic features induced by interferon therapy for hepatitis C infection: report of 2 cases.
    Kajitani K, Kanba S.
    Psychosomatics; 2013 Apr 17; 54(5):506-7. PubMed ID: 23845321
    [No Abstract] [Full Text] [Related]

  • 8. Paroxetine for the prevention of depression induced by interferon alfa.
    Kraus MR, Schäfer A, Scheurlen M.
    N Engl J Med; 2001 Aug 02; 345(5):375-6. PubMed ID: 11484704
    [No Abstract] [Full Text] [Related]

  • 9. Manic episode associated with citalopram therapy for interferon-induced depression in a patient with chronic hepatitis C infection.
    Wu PL, Liao KF, Peng CY, Pariante CM, Su KP.
    Gen Hosp Psychiatry; 2007 Aug 02; 29(4):374-6. PubMed ID: 17591516
    [No Abstract] [Full Text] [Related]

  • 10. Preventing relapse of major depression during interferon-alpha therapy for hepatitis C--A pilot study.
    Gleason OC, Fucci JC, Yates WR, Philipsen MA.
    Dig Dis Sci; 2007 Oct 02; 52(10):2557-63. PubMed ID: 17436092
    [Abstract] [Full Text] [Related]

  • 11. Novel treatment strategies for depression in patients with hepatitis C.
    Loftis JM, Turner EH.
    Psychosomatics; 2010 Oct 02; 51(4):357-8. PubMed ID: 20587769
    [No Abstract] [Full Text] [Related]

  • 12. Does antidepressant medication in patients with hepatitis C undergoing interferon alpha treatment reduce therapeutic efficacy?
    Robaeys G, Wichers MC, De Bie J, Koek GH, Buntinx F, Van Os J.
    Gut; 2009 Jan 02; 58(1):145; author reply 145-6. PubMed ID: 19091833
    [No Abstract] [Full Text] [Related]

  • 13. Prevention of interferon-alpha associated depression in psychiatric risk patients with chronic hepatitis C.
    Schaefer M, Schwaiger M, Garkisch AS, Pich M, Hinzpeter A, Uebelhack R, Heinz A, van Boemmel F, Berg T.
    J Hepatol; 2005 Jun 02; 42(6):793-8. PubMed ID: 15885349
    [Abstract] [Full Text] [Related]

  • 14. Citalopram for the prevention of depression and its consequences in HIV-hepatitis C coinfected individuals initiating pegylated interferon/ribavirin therapy: a multicenter randomized double-blind placebo-controlled trial.
    Klein MB, Lee T, Brouillette MJ, Sheehan NL, Walmsley S, Wong DK, Conway B, Hull M, Cooper C, Haidar S, Vezina S, Annable L, Young S, Zubyk W, Singer J.
    HIV Clin Trials; 2014 Jun 02; 15(4):161-75. PubMed ID: 25143025
    [Abstract] [Full Text] [Related]

  • 15. Interferon-induced depression treated with citalopram.
    Farah A.
    J Clin Psychiatry; 2002 Feb 02; 63(2):166-7. PubMed ID: 11874221
    [No Abstract] [Full Text] [Related]

  • 16. High rates of sustained virological response in hepatitis C virus-infected injection drug users receiving directly observed therapy with peginterferon alpha-2a (40KD) (PEGASYS) and once-daily ribavirin.
    Waizmann M, Ackermann G.
    J Subst Abuse Treat; 2010 Jun 02; 38(4):338-45. PubMed ID: 20362408
    [Abstract] [Full Text] [Related]

  • 17. Exacerbation of Psychogenic Movement Disorder by Interferon{alpha} Treatment of Hepatitis C.
    Mundt AP, Sarkar R, Winter C, Schaefer M, Ströhle A.
    Psychosomatics; 2007 Jun 02; 48(1):86-7. PubMed ID: 17209157
    [No Abstract] [Full Text] [Related]

  • 18. Bupropion for treatment of interferon-induced depression.
    Malek-Ahmadi P, Ghandour E.
    Ann Pharmacother; 2004 Jun 02; 38(7-8):1202-5. PubMed ID: 15150377
    [Abstract] [Full Text] [Related]

  • 19. Prophylactic treatment with escitalopram of pegylated interferon alfa-2a-induced depression in hepatitis C: a 12-week, randomized, double-blind, placebo-controlled trial.
    Diez-Quevedo C, Masnou H, Planas R, Castellví P, Giménez D, Morillas RM, Martín-Santos R, Navinés R, Solà R, Giner P, Ardèvol M, Costa J, Diago M, Pretel J.
    J Clin Psychiatry; 2011 Apr 02; 72(4):522-8. PubMed ID: 21034680
    [Abstract] [Full Text] [Related]

  • 20. Safety of the treatment of interferon-alpha-induced depression.
    Loftis JM, Hauser P.
    Psychosomatics; 2003 Apr 02; 44(6):524-6. PubMed ID: 14597693
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.